Literature DB >> 17445496

Management of impulse control disorders in Parkinson's disease.

Wendy R Galpern1, Mark Stacy.   

Abstract

Impulse control disorders (ICDs) are a set of behaviors, including pathologic gambling, hypersexuality, compulsive shopping, compulsive eating, and punding, which are now recognized to occur in a subset of patients with Parkinson's disease (PD). Although the underlying pathophysiology of these behaviors is poorly understood, they appear to be associated with the use, and sometimes overuse, of dopaminergic agents prescribed for the treatment of the motor symptoms of PD. At present, there are limited data to support any particular therapeutic strategy. Approaches worth considering in the management of the PD patient with an ICD include reduction or discontinuation of dopamine agonist therapy, trials of various pharmacologic agents, psychosocial interventions, and deep brain stimulation of the subthalamic nucleus. However, the management of each patient must be tailored for the particular clinical setting, and the development of evidence-based treatment strategies awaits future prospective studies and randomized controlled trials.

Entities:  

Year:  2007        PMID: 17445496     DOI: 10.1007/bf02938408

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  38 in total

1.  Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents.

Authors:  S Seedat; S Kesler; D J Niehaus; D J Stein
Journal:  Depress Anxiety       Date:  2000       Impact factor: 6.505

Review 2.  Impulse control disorders: clinical characteristics and pharmacological management.

Authors:  Jon E Grant; Marc N Potenza
Journal:  Ann Clin Psychiatry       Date:  2004 Jan-Mar       Impact factor: 1.567

3.  Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease.

Authors:  Valerie Voon
Journal:  Mov Disord       Date:  2004-04       Impact factor: 10.338

4.  Dopamine agonist therapy for Parkinson disease and pathological gambling.

Authors:  Akiko Imamura; Ryan J Uitti; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2006-05-24       Impact factor: 4.891

5.  Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.

Authors:  H H Fernandez; R Durso
Journal:  Mov Disord       Date:  1998-05       Impact factor: 10.338

6.  Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.

Authors:  Fabio Bandini; Alberto Primavera; Matteo Pizzorno; Leonardo Cocito
Journal:  Parkinsonism Relat Disord       Date:  2006-10-16       Impact factor: 4.891

7.  Clinical features associated with impulse control disorders in Parkinson disease.

Authors:  Gregory Pontone; James R Williams; Susan Spear Bassett; Laur Marsh
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

8.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Authors:  V Voon; K Hassan; M Zurowski; M de Souza; T Thomsen; S Fox; A E Lang; J Miyasaki
Journal:  Neurology       Date:  2006-09-06       Impact factor: 9.910

9.  Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.

Authors:  Kevin J Klos; James H Bower; Keith A Josephs; Joseph Y Matsumoto; J Eric Ahlskog
Journal:  Parkinsonism Relat Disord       Date:  2005-09       Impact factor: 4.891

Review 10.  Dopamine dysregulation syndrome in Parkinson's disease.

Authors:  Andrew H Evans; Andrew J Lees
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

View more
  8 in total

1.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

2.  Impulse control disorders in Parkinson's disease.

Authors:  Mark Stacy
Journal:  F1000 Med Rep       Date:  2009-05-08

3.  Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Authors:  Thilo van Eimeren; Bénédicte Ballanger; Giovanna Pellecchia; Janis M Miyasaki; Anthony E Lang; Antonio P Strafella
Journal:  Neuropsychopharmacology       Date:  2009-09-09       Impact factor: 7.853

Review 4.  Current status of symptomatic medical therapy in Parkinson's disease.

Authors:  Stewart A Factor
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 5.  Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.

Authors:  Roberto Cilia; Thilo van Eimeren
Journal:  Brain Struct Funct       Date:  2011-05-04       Impact factor: 3.270

Review 6.  Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review.

Authors:  Domenico Pirritano; Massimiliano Plastino; Domenico Bosco; Luca Gallelli; Antonio Siniscalchi; Giovambattista De Sarro
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

7.  A survey of impulse control disorders in Parkinson's disease patients in Shanghai area and literature review.

Authors:  Xue-Ping Wang; Ming Wei; Qin Xiao
Journal:  Transl Neurodegener       Date:  2016-02-17       Impact factor: 8.014

8.  Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Authors:  Tiago A Mestre; Antonio P Strafella; Teri Thomsen; Valerie Voon; Janis Miyasaki
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.